Skip to content
AnalystLens

TransUnion 8-K Report, Financial Results (Jul 24, 2025)

Reports
Earnings & Results·Regulation FD·Exhibits & Filings
Filing Date
Filed July 24, 2025
Period End
July 24, 2025
Security
TRU
In the record · 2016–202610-K1110-Q348-K130

TRU filed 11 annual reports (10-K), 34 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jun ’18Jun ’18
  2. Auditor change8-K · Feb ’20Feb ’20
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed July 24, 2025. Cited figures are marked; the original filing is the authoritative source.

TransUnion reported second quarter 2025 results on July 24, 2025 (Exhibit 99.1), with total revenue of $1,140 milliona, up 10 percent (10 percent on a constant currency basis and 9 percent on an organic constant currency basis) from the prior-year quarter.

Net income attributable to TransUnion was $110 millionb, or $0.56 diluted EPS, versus $85 million and $0.44 a year earlier. Adjusted EBITDA was $407 million, up 8 percent, with an Adjusted EBITDA margin of 35.7 percent versus 36.2 percent. U.S. Markets revenue grew 10 percent, led by Financial Services at 17 percent, while International grew 6 percent on an organic constant currency basis.

Management raised its full-year 2025 guidance, now expecting revenue growth of 6 to 7 percent on both reported and organic constant currency bases, with full-year Adjusted Diluted EPS guided to $4.03 to $4.14c. For the third quarter, the company guided revenue of $1,115 million to $1,135 million and Adjusted Diluted EPS of $0.99 to $1.04. The company reported a Leverage Ratio of 2.8x at quarter-end and repurchased $47 million of shares through mid-July.

The earnings presentation (Exhibit 99.2) notes that U.S. Financial Services revenue grew 17 percent, including mortgage up 29 percent, and that organic constant currency growth excluding mortgage was 11 percent for that segment. Management also highlighted the Monevo acquisition, the ongoing technology transformation program, and a target Leverage Ratio below 2.5xd.

Key Highlights

  1. Q2 2025 total revenue of $1,140 million, up 10 percent (9 percent organic constant currency).
  2. Net income attributable to TransUnion of $110 million, or $0.56 diluted EPS, versus $85 million and $0.44 in Q2 2024.
  3. Adjusted EBITDA of $407 million, up 8 percent, with a margin of 35.7 percent versus 36.2 percent a year earlier.
  4. Adjusted Diluted EPS of $1.08 versus $0.99 in the prior-year quarter.
  5. Full-year 2025 revenue growth guidance raised to 6 to 7 percent; Adjusted Diluted EPS guided to $4.03 to $4.14.
  6. U.S. Markets revenue up 10 percent, led by Financial Services up 17 percent; International up 6 percent on an organic constant currency basis.
  7. Leverage Ratio of 2.8x at quarter-end, with $47 million of share repurchases through mid-July 2025.

Frequently Asked Questions

  1. How did TransUnion perform against its own expectations in the second quarter of 2025?

    The company stated that it exceeded second quarter 2025 financial guidance across all key financial metrics, with revenue of $1,140 million and Adjusted EBITDA of $407 million.

  2. What changed in TransUnion's full-year 2025 outlook?

    The company raised its 2025 guidance, now expecting revenue growth of 6 to 7 percent on both reported and organic constant currency bases, and Adjusted Diluted EPS of $4.03 to $4.14. Adjusted EBITDA guidance is $1,580 million to $1,610 million.

  3. What drove growth in the quarter?

    U.S. Financial Services revenue rose 17 percent, with mortgage up 29 percent and Card & Banking up 5 percent, according to the presentation. U.S. Markets overall grew 10 percent, and International grew 6 percent on an organic constant currency basis, with India accelerating to 8 percent.

  4. What guidance did management provide for the third quarter of 2025?

    Management guided third-quarter 2025 reported revenue of $1,115 million to $1,135 million, Adjusted EBITDA of $397 million to $411 million, and Adjusted Diluted EPS of $0.99 to $1.04.

  5. What is the company's balance sheet and capital allocation position?

    Cash and cash equivalents were $688 million at June 30, 2025, and the Leverage Ratio was 2.8x. The company repurchased $47 million of shares through mid-July, and its stated target is a Leverage Ratio below 2.5x.